Jeanri Myburgh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jeanri Myburgh has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
A.C. Paterson
Department of Anatomical Pathology, School of Pathology, University of the Witwatersrand, and the South African Institute for Medical Research
1 shared publication- Admire Dube
University of the Western Cape
1 shared publication - Clarissa Willers
Pharmacen™, Centre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa
1 shared publication - June Teare
Department of Environmental Health, Nelson Mandela University, Gqeberha, South Africa
1 shared publication - Minja Gerber
Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), North-West University, Potchefstroom 2531, South Africa
1 shared publication - Wayne Grayson
University of the Witwatersrand Johannesburg South Africa
1 shared publication
Latest Publications
- Open Access
- 3 October 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (10) , 2413
Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems
The aim was to assess the suitability of three nano-based transdermal drug delivery systems containing ibuprofen: a nano-emulsion, a nano-emulgel, and a colloidal suspension with ibuprofen-loaded nanoparticles. Understanding the transdermal delivery of ibuprofen using nano-based drug delivery systems can lead to more effective pain relief and improved patient compliance. Characterization tests assessed the suitability of the developed drug delivery systems. Membrane release and skin diffusion studies, along with tape stripping, were performed to determine drug release and skin permeation of ibuprofen. In vitro cytotoxicity studies on HaCaT cells were conducted using MTT and neutral red assays to evaluate the safety of the developed drug delivery systems. Characterization studies confirmed stable drug delivery systems with ideal properties for transdermal delivery. Membrane release studies demonstrated the successful release of ibuprofen. In vitro skin diffusion experiments and tape stripping, detecting ibuprofen in the receptor phase, stratum corneum-epidermis, and epidermis-dermis, indicating successful transdermal and topical delivery. The in vitro cytotoxicity studies observed only minor cytotoxic effects on HaCaT cells, indicating the safety of the developed drug delivery systems. The investigation demonstrated promising results for the transdermal delivery of ibuprofen using the developed drug delivery systems, which contributes to valuable insights that may lead to improved pain management strategies.
- 3 October 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (10) , 2413
Open AccessInvestigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems
The aim was to assess the suitability of three nano-based transdermal drug delivery systems containing ibuprofen: a nano-emulsion, a nano-emulgel, and a colloidal suspension with ibuprofen-loaded nanoparticles. Understanding the transdermal delivery of ibuprofen using nano-based drug delivery systems can lead to more effective pain relief and improved patient compliance. Characterization tests assessed the suitability of the developed drug delivery systems. Membrane release and skin diffusion studies, along with tape stripping, were performed to determine drug release and skin permeation of ibuprofen. In vitro cytotoxicity studies on HaCaT cells were conducted using MTT and neutral red assays to evaluate the safety of the developed drug delivery systems. Characterization studies confirmed stable drug delivery systems with ideal properties for transdermal delivery. Membrane release studies demonstrated the successful release of ibuprofen. In vitro skin diffusion experiments and tape stripping, detecting ibuprofen in the receptor phase, stratum corneum-epidermis, and epidermis-dermis, indicating successful transdermal and topical delivery. The in vitro cytotoxicity studies observed only minor cytotoxic effects on HaCaT cells, indicating the safety of the developed drug delivery systems. The investigation demonstrated promising results for the transdermal delivery of ibuprofen using the developed drug delivery systems, which contributes to valuable insights that may lead to improved pain management strategies.
- 1 November 1996
- Published by Wiley in Histopathology
- Vol. 29 (5) , 461-463
Immunohistochemical demonstration of progesterone receptor in hepatobiliary cystadenoma with mesenchymal stroma
A case of hepatobiliary cystadenoma with mesenchymal stroma is documented in which unequivocal immunostaining for progesterone receptors was observed in mesenchymal cells. These cells were negative for oestrogen receptor. This suggests that the proliferation of the stromal component may be related to the presence of endogenous progesterone.
- 1 November 1996
- Published by Wiley in Histopathology
- Vol. 29 (5) , 461-463
Immunohistochemical demonstration of progesterone receptor in hepatobiliary cystadenoma with mesenchymal stroma
A case of hepatobiliary cystadenoma with mesenchymal stroma is documented in which unequivocal immunostaining for progesterone receptors was observed in mesenchymal cells. These cells were negative for oestrogen receptor. This suggests that the proliferation of the stromal component may be related to the presence of endogenous progesterone.